Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Funda Meric-Bernstam

Showing results (61-70 of 685) with videos related to

Pageof 69
Sort By:
NPJ Precision Oncology|January 11, 2023
Antibody-drug conjugates in lung cancer: dawn of a new era?Niamh Coleman, Timothy A Yap, John V Heymach, et al.
Clinical Breast Cancer|December 1, 2010
Deciphering the role of PI3K/Akt/mTOR pathway in breast cancer biology and pathogenesisPriscilla F McAuliffe, Funda Meric-Bernstam, Gordon B Mills, et al.
Cancer|April 5, 2008
Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastasesArgun Akcakanat, Aysegul Sahin, Alexandra N Shaye, et al.
International Journal of Medical Informatics|July 20, 2005
Searching for cancer-related information online: unintended retrieval of complementary and alternative medicine informationMuhammad Walji, Smitha Sagaram, Funda Meric-Bernstam, et al.
International Journal of Medical Informatics|July 27, 2005
Usability of quality measures for online health information: Can commonly used technical quality criteria be reliably assessed?Elmer V Bernstam, Smitha Sagaram, Muhammad Walji, et al.
Cancer Research|February 26, 2013
Everolimus in advanced pancreatic neuroendocrine tumors: the clinical experienceJames C Yao, Alexandria T Phan, Valentine Jehl, et al.
Nutrition and Cancer|February 5, 2011
The effect of leucine restriction on Akt/mTOR signaling in breast cancer cell lines in vitro and in vivoGopal Singh, Argun Akcakanat, Chandeshwar Sharma, et al.
Plos One|November 9, 2013
CanDrA: cancer-specific driver missense mutation annotation with optimized featuresYong Mao, Han Chen, Han Liang, et al.
RNA Biology|December 23, 2008
RNA-binding specificity of Y-box protein 1Jinjiang Dong, Argun Akcakanat, David N Stivers, et al.
Endocrine-Related Cancer|March 4, 2008
Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumorsAmy Moreno, Argun Akcakanat, Mark F Munsell, et al.
Pageof 69

Showing results (61-70 of 685) with videos related to

Sort By:
Pageof 69
NPJ Precision Oncology|January 11, 2023
Antibody-drug conjugates in lung cancer: dawn of a new era?Niamh Coleman, Timothy A Yap, John V Heymach, et al.
Clinical Breast Cancer|December 1, 2010
Deciphering the role of PI3K/Akt/mTOR pathway in breast cancer biology and pathogenesisPriscilla F McAuliffe, Funda Meric-Bernstam, Gordon B Mills, et al.
Cancer|April 5, 2008
Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastasesArgun Akcakanat, Aysegul Sahin, Alexandra N Shaye, et al.
International Journal of Medical Informatics|July 20, 2005
Searching for cancer-related information online: unintended retrieval of complementary and alternative medicine informationMuhammad Walji, Smitha Sagaram, Funda Meric-Bernstam, et al.
International Journal of Medical Informatics|July 27, 2005
Usability of quality measures for online health information: Can commonly used technical quality criteria be reliably assessed?Elmer V Bernstam, Smitha Sagaram, Muhammad Walji, et al.
Cancer Research|February 26, 2013
Everolimus in advanced pancreatic neuroendocrine tumors: the clinical experienceJames C Yao, Alexandria T Phan, Valentine Jehl, et al.
Nutrition and Cancer|February 5, 2011
The effect of leucine restriction on Akt/mTOR signaling in breast cancer cell lines in vitro and in vivoGopal Singh, Argun Akcakanat, Chandeshwar Sharma, et al.
Plos One|November 9, 2013
CanDrA: cancer-specific driver missense mutation annotation with optimized featuresYong Mao, Han Chen, Han Liang, et al.
RNA Biology|December 23, 2008
RNA-binding specificity of Y-box protein 1Jinjiang Dong, Argun Akcakanat, David N Stivers, et al.
Endocrine-Related Cancer|March 4, 2008
Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumorsAmy Moreno, Argun Akcakanat, Mark F Munsell, et al.
Pageof 69